You are here: Industry Insights > Immuno

News List

Personalized Vaccines: How Neoantigens Are Changing Cancer Immunotherapy Nurah Ekhlaque
April 07, 2025
Explore how neoantigen-based vaccines are revolutionizing cancer immunotherapy by enabling personalized, targeted treatment strategies for better outcomes.
Future Prospects of Small Molecule and Monoclonal Antibody Drugs in Oncology and Immunology Krebs Qin
October 18, 2024
Specifically, there is a balance between small molecules and monoclonal antibody drugs (mAbs) in the realm of oncology super blockbuster drugs, while immunology appears dominated by monoclonal antibodies and protein-based treatments.
Immuno-Oncology: Current Market Landscape and Future Trends（1） Neeta Ratanghayra
September 18, 2024
Immune Checkpoint Inhibitors & Challenges and Future Directions.
Immuno-Oncology: Current Market Landscape and Future Trends（2） Neeta Ratanghayra
September 18, 2024
CAR-T Therapy & Antibody–Drug Conjugates.
Immunoconjugates: Biological Missiles for Diagnosis and Treatment Suzanne Elvidge
August 02, 2024
Immunoconjugates already play an important role in the treatment of cancer, and their role is likely to expand into other therapeutic indications.
Research Progress on the Mechanisms of Immunomodulatory Effects of Plant Polysaccharides (Part Ⅱ) Xiaonisha
September 09, 2025
Dendritic cells (DCs) are widely recognized as the most potent antigen-presenting cells (APCs) that bridge innate and adaptive immunity.
Research Progress on the Mechanisms of Immunomodulatory Effects of Plant Polysaccharides (Part I) Xiaonisha
September 08, 2025
Plant polysaccharides, abbreviated as PPS, are compounds composed of many identical or different monosaccharides linked by α- or β-glycosidic bonds.
Golden Pen Award | The Current Status of Application of Biomembrane Nanocarrier Drug Delivery Systems in Tumor Immunotherapy Xiaonisha
August 27, 2025
In recent years, the excellent biocompatibility, modifiability, and low immunogenicity of biomembrane nanosystems have significantly advanced the development of tumor immunotherapy.
Breakthroughs in Melanoma Immunotherapy & RNA Vaccines Daivd Orchard Webb/PharmaSources
July 03, 2023
Melanoma is a type of skin cancer that develops from pigment-producing cells called melanocytes.
O-drug Approved as First-line Immunotherapy for Gastric Cancer and What Other Domestic Counterparts to Expect PharmaSources/Yefenghong
May 08, 2021
O-drug is the first approved immunotherapy for first-line treatment of gastric cancer.